Development and validation of a survival prediction model and risk stratification for pancreatic neuroendocrine neoplasms

被引:3
|
作者
Lu, Z. [1 ]
Li, T. [2 ,3 ,4 ]
Liu, C. [1 ]
Zheng, Y. [1 ,4 ]
Song, J. [1 ]
机构
[1] Chinese Acad Med Sci, Dept Gen Surg, Dept HepatoBilio Pancreat Surg, Beijing Hosp,Natl Ctr Gerontol,Inst Geriatr Med, 1 DaHua Rd, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci, Natl Ctr Clin Labs, Beijing Hosp, Natl Ctr Gerontol, 1 Dahua Rd, Beijing 100730, Peoples R China
[3] Chinese Acad Med Sci, Inst Geriatr Med, 1 Dahua Rd, Beijing 100730, Peoples R China
[4] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing, Peoples R China
关键词
Pancreatic neuroendocrine neoplasm; Risk factors; Prediction model; Risk stratification; Cancer-specific survival; TUMORS; GUIDELINES; DIAGNOSIS; MANAGEMENT; CANCER;
D O I
10.1007/s40618-022-01956-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose We explored risk variables associated with cancer-specific survival (CSS) in patients with pancreatic neuroendocrine neoplasms (PNENs) and created a network dynamic nomogram model to predict patient survival time. Methods A total of 7750 patients with PNENs were included in this analysis, including 134 with functional PNENs and 7616 with nonfunctional PNENs. Clinical feature and prognosis differences between functional and nonfunctional PNENs were compared. Independent prognostic factors affecting CSS were analyzed by univariate and multifactorial Cox regression. Nomogram and web-based prognosis prediction of PNENs were developed and validated by C indices, decision curve analysis, and calibration plots. Results Patients with functional PNENs were younger at diagnosis than those with nonfunctional PNENs. Functional PNENs had better prognoses than nonfunctional PNENs (5-year survival rates: 78.55% and 71.10%, respectively). Univariate and multifactorial Cox regression analyses showed that tumor infiltration (T), nodal metastasis (N), metastasis (M), tumor site, differentiation grade, age, marital status, and surgical treatment were independent prognostic risk factors for CSS, which were included in the prognostic nomogram and web-based prognosis calculator. The calibration plots and decision curve analysis showed that the nomogram had excellent prediction and clinical practical ability. The C indices for CSS in the training and validation cohorts were 0.848 (95% CI 0.838-0.8578) and 0.823 (95% CI 0.807-0.839), respectively. We scored all patients according to the nomogram and divided patients into three different risk groups. The prognosis of the low-risk population was significantly better than those of the middle- and high-risk populations based on Kaplan-Meier survival curve. Conclusion We analyzed the clinical features of PNENs and developed a convenient and web dynamic nomogram to predict CSS.
引用
收藏
页码:927 / 937
页数:11
相关论文
共 50 条
  • [21] Development and validation of a risk stratification model for prediction of disability and hospitalisation in patients with heart failure: a study protocol
    Garcia-Olmos, Luis
    Rodriguez-Salvanes, Francisco
    Batlle-Perez, Maurice
    Aguilar-Torres, Rio
    Porro-Fernandez, Carlos
    Garcia-Cabello, Alfredo
    Carmona, Montserrat
    Ruiz-Alonso, Sergio
    Garrido-Elustondo, Sofia
    Alberquilla, Angel
    Maria Sanchez-Gomez, Luis
    Sanchez de Madariaga, Ricardo
    Monge-Navarrete, Elena
    Benito-Ortiz, Luis
    Banos-Perez, Nicolas
    Simon-Puerta, Amaya
    Lopez Rodriguez, Ana Belen
    Angel Martinez-Alvarez, Miguel
    Angeles Velilla-Celma, Maria
    Isabel Bernal-Gomez, Maria
    BMJ OPEN, 2017, 7 (06):
  • [22] Establishment and validation of a nomogram prognostic prediction model for 490 gastric neuroendocrine neoplasms in a single center
    Zhang, B.
    Zhang, K.
    Chen, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S104 - S104
  • [23] Predicting Delirium Risk Using an Automated Mayo Delirium Prediction Tool: Development and Validation of a Risk-Stratification Model
    Pagali, Sandeep R.
    Miller, Donna
    Fischer, Karen
    Schroeder, Darrell
    Egger, Norman
    Manning, Dennis M.
    Lapid, Maria, I
    Pignolo, Robert J.
    Burton, M. Caroline
    MAYO CLINIC PROCEEDINGS, 2021, 96 (05) : 1229 - 1235
  • [24] Development of a stratification tool to identify pancreatic intraductal papillary mucinous neoplasms at lowest risk of progression
    Overbeek, Kasper A.
    Alblas, Maaike
    Gausman, Valerie
    Kandel, Pujan
    Schweber, Adam B.
    Brooks, Christian
    Van Riet, Priscilla A.
    Wallace, Michael B.
    Gonda, Tamas A.
    Cahen, Djuna L.
    Bruno, Marco J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (07) : 789 - 799
  • [25] Novel Recurrence Risk Stratification of Resected Pancreatic Neuroendocrine Tumor
    Gao, H.
    Yu, X.
    NEUROENDOCRINOLOGY, 2018, 106 : 142 - 142
  • [26] DEVELOPMENT AND VALIDATION OF RISK PREDICTION MODEL FOR INTERVENTION IN PANCREATIC FLUID COLLECTION : PROSPECTIVE COHORT STUDY
    Choi, Youn-i
    Cho, Jae Hee
    Kim, YeonSuk
    GASTROENTEROLOGY, 2019, 156 (06) : S1033 - S1033
  • [27] Novel recurrence risk stratification of resected pancreatic neuroendocrine tumor
    Gao, Heli
    Liu, Liang
    Wang, Wenquan
    Xu, Huaxiang
    Jin, Kaizhou
    Wu, Chuntao
    Qi, Zihao
    Zhang, Shirong
    Liu, Chen
    Xu, Jinzhi
    Ni, Quanxing
    Yu, Xianjun
    CANCER LETTERS, 2018, 412 : 188 - 193
  • [28] A Cure Model Survival Analysis of Patients Affected by Pancreatic Neuroendocrine Neoplasms: The Bologna ENETS Center Experience
    Ricci, C.
    Campana, D.
    Ingaldi, C.
    Alberici, L.
    Mosconi, C.
    Ambrosini, V
    Brighi, N.
    Santini, D.
    Pagano, N.
    Casadei, R.
    NEUROENDOCRINOLOGY, 2019, 108 : 259 - 259
  • [29] Establishment and validation of the survival prediction risk model for appendiceal cancer
    Liu, Tao
    Mi, Junli
    Wang, Yafeng
    Qiao, Wenjie
    Wang, Chenxiang
    Ma, Zhijun
    Wang, Cheng
    FRONTIERS IN MEDICINE, 2022, 9
  • [30] Development and validation of prognostic nomograms for patients with periampullary neuroendocrine neoplasms
    Chen, J.
    Chen, Q.
    Zhou, J.
    Zhao, H.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 66 - 66